These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15920069)

  • 1. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.
    Sone H; Mizuno S; Fujii H; Yoshimura Y; Yamasaki Y; Ishibashi S; Katayama S; Saito Y; Ito H; Ohashi Y; Akanuma Y; Yamada N;
    Diabetes Care; 2005 Jun; 28(6):1463-71. PubMed ID: 15920069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS).
    Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N
    J Atheroscler Thromb; 2009 Aug; 16(4):380-7. PubMed ID: 19672033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
    Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H
    Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and risk of major coronary events among the urban diabetic patients: North Indian Diabetes and Cardiovascular Disease Study-NIDCVD-2.
    Bhatti GK; Bhadada SK; Vijayvergiya R; Mastana SS; Bhatti JS
    J Diabetes Complications; 2016; 30(1):72-8. PubMed ID: 26271411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of blood pressure and other components of the metabolic syndrome on the development of cardiovascular disease.
    Kang G; Guo L; Guo Z; Hu X; Wu M; Zhou Z; Zhou H; Liu S; Chen F
    Circ J; 2010 Mar; 74(3):456-61. PubMed ID: 20057161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome components and prevalence of cardiovascular disease among type 2 diabetic patients in Malaysia.
    Tan MC; Wong TW; Ng OC; Joseph A; Hejar AR
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):226-35. PubMed ID: 24964674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of two metabolic syndrome definitions in the estimation of cardiovascular disease among hypertensive patients.
    Hirota AH; Rodrigues CJ; Borges RL; Ribeiro AB; Zanella MT; Batista MC
    J Clin Hypertens (Greenwich); 2010 Aug; 12(8):588-96. PubMed ID: 20695935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
    Nilsson PM; Engström G; Hedblad B
    Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults.
    Hosseinpanah F; Asghari G; Barzin M; Golkashani HA; Azizi F
    Int J Cardiol; 2013 Sep; 168(1):369-74. PubMed ID: 23041003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study.
    Birarra MK; Gelayee DA
    BMC Cardiovasc Disord; 2018 Jul; 18(1):149. PubMed ID: 30016936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of metabolic syndrome and constitutional medicine for the prediction of cardiovascular disease.
    Cho NH; Kim JY; Kim SS; Shin C
    Diabetes Metab Syndr; 2013; 7(4):226-32. PubMed ID: 24290090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study.
    Ninomiya T; Kubo M; Doi Y; Yonemoto K; Tanizaki Y; Rahman M; Arima H; Tsuryuya K; Iida M; Kiyohara Y
    Stroke; 2007 Jul; 38(7):2063-9. PubMed ID: 17525396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
    PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria.
    Hwang IC; Kim KK; Jee SH; Kang HC
    Yonsei Med J; 2011 Mar; 52(2):220-6. PubMed ID: 21319338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study.
    Doi Y; Ninomiya T; Hata J; Yonemoto K; Arima H; Kubo M; Tanizaki Y; Iwase M; Iida M; Kiyohara Y
    Stroke; 2009 Apr; 40(4):1187-94. PubMed ID: 19265058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
    Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
    Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of smoking and metabolic syndrome for incidence of cardiovascular disease--comparison of relative contribution in urban Japanese population: the Suita study.
    Higashiyama A; Okamura T; Ono Y; Watanabe M; Kokubo Y; Okayama A
    Circ J; 2009 Dec; 73(12):2258-63. PubMed ID: 19838005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome increased risk of cardiovascular events in Chinese--a community based study.
    Wang C; Hou X; Bao Y; Pan J; Zuo Y; Zhong W; Jia W; Xiang K
    Int J Cardiol; 2010 Mar; 139(2):159-65. PubMed ID: 19046783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.